FMI's Revelation: Addison Disease Testing Market Set to Reach US$ 349.7 Million with 3.4% CAGR by 2033
The worldwide Addison’s Disease Testing market is poised to achieve a total of US$ 249.8 million by the year 2023, with an anticipated Compound Annual Growth Rate (CAGR) of 3.4%. Looking ahead to 2033, this market is projected to reach a substantial valuation of US$ 349.7 million. The increasing adoption of emergenc...
Source: pharmiweb.com